All Stories

  1. Process to radioactive iodine treatment for Graves’ hyperthyroidism: condemned or absolved?
  2. Natural Killer Cells in Graves’ Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls
  3. Nutritional Approach in Thyroid Disease: Reality and Myths to Dispel
  4. Assessment of the Correlation between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Prospective Study
  5. Autoimmune thyroid diseases
  6. Role of regulatory T cells in pathogenesis and therapeutics of Graves’ disease and Graves’ orbitopathy
  7. Serum thyroid hormone-binding proteins
  8. Smoking and the thyroid
  9. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors
  10. Regulatory T Cells in the Pathogenesis of Graves’ Disease
  11. Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records
  12. Editorial: Immunocellular mechanisms and endocrine organs
  13. Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
  14. How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
  15. Clinical and oncological outcomes in single-stage versus staged surgery for pediatric craniopharyngiomas: a multicenter retrospective study
  16. A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease
  17. The Old and the New in Subacute Thyroiditis: An Integrative Review
  18. Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
  19. Management of Graves’ hyperthyroidism: present and future
  20. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review
  21. SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?
  22. Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis
  23. Paraneoplastic hyperthyroidism in hCG-secreting metastatic testicular cancer
  24. Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study
  25. Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression
  26. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
  27. Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”
  28. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
  29. Liraglutide is an effective drug for the treatment of obesity also in real life
  30. Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells
  31. When primary hyperparathyroidism comes as good news
  32. Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?
  33. Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study
  34. The interplay between thyroid and liver: implications for clinical practice
  35. Oral steroid prophylaxis for Graves’ orbitopathy after radioactive iodine treatment for Graves’ disease is not only effective, but also safe
  36. Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review
  37. Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study
  38. Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management
  39. Pre-operative evaluation of obese patients admitted for bariatric surgery: observations suggesting the introduction of a detailed screening for thyroid diseases
  40. Decreased levels of vitamin D may favor diabetes
  41. Vitamin D, visceral obesity and metabolic diseases
  42. Demographic and baseline characteristics of an obese population admitted for bariatric surgery in a secondary care centre
  43. Metabolic profile reversal after bariatric surgery
  44. Physical performance in newly diagnosed hypothyroidism: a pilot study
  45. The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study
  46. Masked hypertension in newly diagnosed hypothyroidism: a pilot study
  47. Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs
  48. Pituitary apoplexy during pregnancy: a rare, but dangerous headache
  49. Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center